Novavax’s COVID-19 Vaccine Shows Efficacy in Monkeys, but Does That Translate to Humans?

Maryland-based vaccine company Novavax said its COVID-19 vaccine candidate, NVX‑CoV2373, prevented SARS-CoV-2 infection in monkeys, hinting that the product could likewise prove effective in humans.